Sign in
Not yet taking people in United StatesNo phase

PRECISION-CPR: PRecision-Controlled Ventilation in CPR

Key facts

Who runs it
Rush University Medical Center
Where
Chicago, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Status
Not yet recruiting
People taking part
852 people, planned
Started
1 Sept 2026
Expected to end
31 Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Precision-Controlled Ventilation with Real-Time Feedback
  • Standard Manual Ventilation During CPR
Record updated
11 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Adult patients (18 years or older) with in-hospital cardiac arrest receiving manual ventilation via bag-mask or artificial airway

Who cannot take part

  • Patients receiving Extracorporeal Membrane Oxygenation (ECMO)
  • Inability to estimate predicted body weight (e.g., extreme body habitus or lack of height data)
  • Known pregnancy

Where in United States

Also in 1 other country, 1 site

  • Rush University Medical CenterChicago, United StatesContact: JIE LI, PhDNot yet recruiting

About the trial

What the trial wants to find out

Cardiac arrest is a life-threatening emergency that requires immediate treatment with cardiopulmonary resuscitation (CPR). While chest compressions circulate blood, manual ventilation provides oxygen to the patient. Current CPR guidelines recommend specific ventilation rates and tidal volumes, but studies show that clinicians often deliver too much or too little ventilation due to a lack of monitoring tools, potentially reducing the effectiveness of CPR and impacting survival.

Read full original descriptionShow less

The PRECISION-CPR study is a multi-center, randomized controlled trial designed to evaluate whether using real-time feedback devices to precisely control ventilation during CPR can improve patient outcomes. Adult patients experiencing in-hospital cardiac arrest will be randomized to receive either standard manual ventilation guided by clinician experience or precision-controlled ventilation tailored to the patient's predicted body weight using real-time monitoring devices.

The primary outcome of the study will be return of spontaneous circulation (ROSC). Secondary outcomes will include survival to hospital discharge, neurological recovery, and other clinical measures. By addressing the limitations of current ventilation practices, this study aims to generate evidence to guide future resuscitation guidelines and improve survival rates after cardiac arrest.

The 2 groups in the trial

  • Precision-Controlled Ventilation with Real-Time FeedbackTreatment being tested

    Patients will receive manual ventilation during CPR using real-time feedback devices (EOlife) to guide tidal volume (6-8 mL/kg predicted body weight) and ventilation rate (10 breaths per minute) delivery, ensuring adherence to guideline-recommended ventilation parameters.

  • Standard of Care Ventilation During CPRExisting treatment, for comparison

    Patients will receive manual ventilation during CPR per standard practice without real-time feedback, using clinician judgment for tidal volume (visible chest rise) and ventilation rate, consistent with American Heart Association guidelines.

    Treatment: Standard Manual Ventilation During CPR

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial
Record updated
11 March 2026